Stone House Investment Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.7K Buy
182
+8
+5% +$526 ﹤0.01% 407
2026
Q1
$12.4K Sell
174
-32
-16% -$2.52K ﹤0.01% 325
2025
Q4
$16.9K Buy
206
+12
+6% +$935 ﹤0.01% 266
2025
Q3
$14.6K Hold
194
– – ﹤0.01% 254
2025
Q2
$14.4K Hold
194
– – ﹤0.01% 233
2025
Q1
$15.7K Buy
+194
New +$16.7K ﹤0.01% 224
2024
Q4
– Sell
-57
Closed -$5.35K – 173
2024
Q3
$5.35K Hold
57
– – ﹤0.01% 268
2024
Q2
$4.44K Sell
57
-26
-31% -$2.12K ﹤0.01% 281
2024
Q1
$7.55K Sell
83
-224
-73% -$18.6K ﹤0.01% 254
2023
Q4
$23.7K Hold
307
– – 0.01% 114
2023
Q3
$20.9K Buy
307
+20
+7% +$1.46K 0.01% 117
2023
Q2
$23.3K Buy
287
+250
+676% +$19.9K 0.01% 107
2023
Q1
$3.04K Buy
+37
New +$2.64K ﹤0.01% 225

Other funds holding GEHC

Stone House Investment Management's GEHC Position: Q2 2026 in Review

Stone House Investment Management increased its GE HealthCare (GEHC) stake by 4.6% in Q2 2026, buying an estimated $526 and bringing the position to 182 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #407.

Stone House Investment Management first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $23.7K in Q4 2023. 1,233 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Stone House Investment Management held 182 shares of GE HealthCare worth $11.7K as of Q2 2026.
  • Stone House Investment Management bought 8 GE HealthCare shares in Q2 2026, an estimated $526.
  • GE HealthCare made up ﹤0.01% of Stone House Investment Management's portfolio in Q2 2026, its #407 holding.
  • Stone House Investment Management first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Stone House Investment Management's GE HealthCare position peaked at $23.7K in Q4 2023.
  • 1,233 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.